Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Novabay Pharmaceuticals Inc (AMEX: NBY) closed the day trading at $4.57 down -15.84% from the previous closing price of $5.43. In other words, the price has decreased by -$15.84 from its previous closing price. On the day, 1.11 million shares were traded. NBY stock price reached its highest trading level at $5.24 during the session, while it also had its lowest trading level at $4.37.
Ratios:
For a better understanding of NBY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 1.98. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
In the most recent recommendation for this company, Ladenburg Thalmann on September 18, 2019, initiated with a Buy rating and assigned the stock a target price of $1.10. On July 06, 2018, H.C. Wainwright reiterated its Buy ratingand also kept the price unchanged to $4. Laidlaw reiterated its Buy rating for the stock on November 15, 2017, while the target price for the stock was revised from $10 to $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 03 ’25 when POPLAR POINT CAPITAL PARTNERS bought 22,976 shares for $0.56 per share. The transaction valued at 12,929 led to the insider holds 1,015,462 shares of the business.
POPLAR POINT CAPITAL PARTNERS bought 4,538 shares of NBY for $2,367 on Apr 04 ’25. The 10% Owner now owns 1,020,000 shares after completing the transaction at $0.52 per share. On Apr 02 ’25, another insider, POPLAR POINT CAPITAL PARTNERS, who serves as the 10% Owner of the company, bought 917 shares for $0.58 each. As a result, the insider paid 532 and bolstered with 992,486 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBY now has a Market Capitalization of 575869184 and an Enterprise Value of 578847104. For the stock, the TTM Price-to-Sale (P/S) ratio is 203.49. Its current Enterprise Value per Revenue stands at 56.188 whereas that against EBITDA is -113.433.
Stock Price History:
The Beta on a monthly basis for NBY is 0.27, which has changed by 8.526316 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, NBY has reached a high of $6.47, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is 183.60%, while the 200-Day Moving Average is calculated to be 416.74%.
Shares Statistics:
Over the past 3-months, NBY traded about 979.42K shares per day on average, while over the past 10 days, NBY traded about 4222490 shares per day. A total of 126.01M shares are outstanding, with a floating share count of 124.81M. Insiders hold about 0.96% of the company’s shares, while institutions hold 0.99% stake in the company. Shares short for NBY as of 1764288000 were 63942 with a Short Ratio of 0.07, compared to 1761868800 on 145618. Therefore, it implies a Short% of Shares Outstanding of 63942 and a Short% of Float of 0.05.
